Effects of anti-VEGF antibody on blood-brain barrier disruption in focal cerebral ischemia

Experimental Neurology

Volumn 204, Issue 1, 2007, Pages 283-287

  Chi, Oak Z ^a   Hunter, Christine ^a   Liu, Xia ^a   Weiss, Harvey R ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Blood brain barrier; Focal cerebral ischemia; VEGF; VEGF antibody

Indexed keywords

2 AMINO 2 METHYLPROPIONIC ACID; DEXTRAN; ISOFLURANE; SODIUM CHLORIDE; VASCULOTROPIN; VASCULOTROPIN ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL VENTILATION; BLOOD BRAIN BARRIER; BLOOD GAS; BRAIN CORTEX; BRAIN ISCHEMIA; BRAIN TEMPERATURE; CONTROLLED STUDY; CORRELATION COEFFICIENT; CRANIOTOMY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL ANALYSIS; VITAL SIGN;

ADMINISTRATION, TOPICAL; AMINOISOBUTYRIC ACIDS; ANIMALS; ANTIBODIES; BLOOD-BRAIN BARRIER; BRAIN ISCHEMIA; CEREBRAL CORTEX; DEXTRANS; MALE; RATS; RATS, WISTAR; TISSUE DISTRIBUTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33847332493     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2006.11.001     Document Type: Article

References (35)

1. Albayrak S., Zhao O., Siesjo B.K., and Smith M.L. Effect of transient focal ischemia on BBB permeability in the rat: correlation to cell injury. Acta Neuropathol. (Berl.) 94 (1997) 158-163
2. Asano M., Yukita A., Matsumoto S., and Suzuki H. Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to vascular endothelial growth factor/vascular permeability factor. Cancer Res. 55 (1995) 5226-5231
3. Bao W.L., Lu S.D., Wang H., and Sun F.Y. Intraventricular vascular endothelial growth factor antibody increases infarct volume following transient cerebral ischemia. Acta Pharmacol. Sin. 20 4 (1999) 313-318
4. Banai S., Jaklitsch M.T., Shou M., Lazarous D.F., Scheinowitz M., Biro S., Epstein S.E., and Unger E.F. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 89 (1994) 2183-2189
5. 2+-dependent pathway. Am. J. Physiol. Heart Circ. Physiol. 273 (1997) H687-H694
6. Breslin J.W., Pappas P.J., Cerveira J.J., Hobson R.W., and Duran W.N. VEGF increases endothelial permeability by separate signaling pathways involving ERK-1/2 and nitric oxide. Am. J. Physiol. Heart Circ. Physiol. 284 (2003) H92-H100
7. Chi O.Z., Wei H.M., Sinha A.K., and Weiss H.R. Effects of inhibition of nitric oxide synthase on blood-brain barrier transport in focal cerebral ischemia. Pharmacology 48 (1994) 363-367
8. 2 supply/consumption heterogeneity. J. Cereb. Blood Flow Metab. 16 (1996) 327-333
9. Chi O.Z., Chang Q., and Weiss H.R. Effects of topical N-methyl-d-aspartate on blood-brain barrier permeability in the cerebral cortex of normotensive and hypertensive rats. Neurol. Res. 19 (1997) 539-544
10. Chi O.Z., Barsoum S., Wen Y., Liu X., and Weiss H.R. 17β-estradiol prevents blood-brain barrier disruption induced by VEGF. Horm. Metab. Res. 36 5 (2004) 272-276
11. Chi O.Z., Hunter C., Liu X., and Weiss H.R. Effects of VEGF and nitric oxide synthase inhibition on blood-brain barrier disruption in the ischemic and non-ischemic cerebral cortex. Neurol. Res. 27 (2005) 864-868
12. Croll S.D., and Wiegand S.J. Vascular growth factors in cerebral ischemia. Mol. Neurobiol. 23 (2001) 121-135
13. Ferrara N., Gerber H.P., and LeCouter J. The biology of VEGF and its receptors. Nat. Med. 9 6 (2003) 669-676
14. Fischer S., Wobben M., Marti H.H., Renz D., and Schaper W. Hypoxia-induced hyperpermeability in brain microvessel endothelial cells involves VEGF-mediated changes in the expression of zonula occludens-1. Microvasc. Res. 63 (2002) 70-80
15. Gross P.M., Blasberg R.G., Fenstermacher J.D., and Patlak C.S. The microcirculation of rat circumventricular organs and pituitary gland. Brain Res. Bull. 18 (1987) 73-85
16. Han M.K., Kim M., Bae S.Y., Kang L., Han S.Y., Lee Y.S., Rha J.H., Kim S.U., and Roh J.K. VEGF protects human cerebral hybrid neurons from in vitro ischemia. NeuroReport 15 5 (2004) 847-850
17. Heiss J.D., Papavassiliou E., Merrill M.J., Nieman L., Knightly J.J., Walbridge S., Edwards N.A., and Oldfield E.H. Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor. J. Clin. Invest. 98 6 (1996) 1400-1408
18. Hippenstiel S., Krull M., Ikemann A., Risau W., Clauss M., and Suttorp N. VEGF induces hyperpermeability by a direct action on endothelial cells. Am. J. Physiol.: Lung Cell Mol. Physiol. 274 (1998) L678-L684
19. Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci. 20 (1997) 132-139
20. Jin K.L., Mao X.O., and Greenberg D.A. Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. Proc. Natl. Acad. Sci. U. S. A. 97 18 (2000) 10242-10247
21. Kristian T., and Siesjo B.K. Calcium in ischemic cell death. Stroke 29 (1998) 705-718
22. Mayhan W.G. VEGF increases permeability of the blood-brain barrier via a nitric oxide synthase/cGMP-dependent pathway. Am. J. Physiol.: Cell Physiol. 276 (1999) C1148-C1153
23. Murakami K., Kondo T., and Chan P.H. Blood-brain barrier disruption, edema formation and apoptotic neuronal death following cold injury. Acta Neurochir. Suppl. (Wien) 70 (1997) 234-236
24. Murohara T., Horowitz J.R., Silver M., Tsurumi Y., Chen D., Sullivan A., and Isner J.M. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation 97 (1998) 99-107
25. Matsumoto T., and Claesson-Welsh L. VEGF receptor signal transduction. Sci. STKE 112 (2001) RE21
26. Nag S. The blood-brain barrier and cerebral angiogenesis: lessons from the cold-injury model. Trends Mol. Med. 8 1 (2002) 38-44
27. Plate K.H. Mechanisms of angiogenesis in the brain. J. Neurpathol. Exp. Neurol. 58 (1999) 313-320
28. Schoch H.J., Fischer S., and Marti H.H. Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain. Brain 125 11 (2002) 2549-2557
29. Sirois M.D., and Edelman E.R. VEGF effect on vascular permeability is mediated by synthesis of platelet activating factor. Am. J. Physiol.: Heart Circ. Physiol. 272 (1997) H2746-H2756
30. van Bruggen N., Thibodeaux H., Palmer J.T., Lee W.P., Fu L., Cairns B., Tumas D., Gerlai R., Williams S.P., van Lookeren Campagne M., and Ferrara N. VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain. J. Clin. Invest. 104 11 (1999) 1613-1620
31. Wang R.G., and Zhu X.Z. Expression of angiopoietin-2 and vascular endothelial growth factor in mice cerebral cortex after permanent focal cerebral ischemia. Acta Pharmacol. Sin. 23 (2002) 405-411
32. Yuan F., Chen Y., Dellian M., Safabakhsh N., Ferrara N., and Jain R. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 14765-14770
33. Zhang Z., and Chopp M. Vascular endothelial growth factor and angiopoietins in focal cerebral ischemia. Trends Cardiovasc. Med. 12 (2002) 62-66
34. Zhang Z.G., Zhang L., Jiang Q., Zhang R., Davies K., Powers C., van Bruggen N., and Chopp M. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J. Clin. Invest. 106 (2000) 829-838
35. Zhang Z.G., Zhang L., Tsang W., Soltanian-Zadeh H., Morris D., Zhang R., Goussev A., Powers C., Yeich T., and Chopp M. Correlation of VEGF and angiopoietin expression with disruption of blood-brain barrier and angiogenesis after focal cerebral ischemia. J. Cereb. Blood Flow Metab. 22 4 (2002) 379-392